BioPharma APAC - Leading Source of Biopharmaceutical Intelligence in Asia Pacific

Medical Diagnostic

Otsuka Advances Centanafadine With FDA Filing To Bring a First in Class ADHD Therapy to Children, Adolescents, and Adults

Centanafadine is an investigational compound for the treatment of ADHD in children, adolescents, and adults. It is a first-in-class norepinephrine, dop...

November 26, 2025 | News

Pin Therapeutics Begins First Human Study of CK1 Alpha Degrader PIN 5018 for Rare Cancer

Pin Therapeutics, a clinical-stage biotechnology company specializing in targeted protein degradation, announced on November 20 that it has...

November 25, 2025 | News

Abbott to Acquire Exact Sciences for $21 Billion to Transform Cancer Diagnostics

Acquisition adds a new growth vertical to Abbott's already high single-digit growth profile, gaining leadership in the fast-growing $60 billion U.S. canc...

November 21, 2025 | News

Rafa Laboratories Secures Major BARDA Contract to Advance Intramuscular Tranexamic Acid for Trauma Care

Rafa Laboratories, a global leader in Chemical, Biological, Radiological, and Nuclear hazards medical countermeasures and Biodefense, announced it ha...

November 20, 2025 | News

AGC Biologics and Repair Biotechnologies Partner to Advance a Novel mRNA Therapy for Atherosclerotic Disease

Partnership leverages AGC Biologics’ cost-effective and dependable cGMP mRNA and LNP capabilities AGC Biologics announced it is partnering w...

November 20, 2025 | News

Bio Techne Licenses AI Designed NovoBody Duo Molecules Under Exclusive Agreement With Monod Bio

Partnership strengthens Bio-Techne's leadership in AI-enabled protein innovation NovoBody™ Duo molecules offer multi-specific binding capabilities...

November 19, 2025 | News

Genesis MedTech And NUHS Launch AI Innovation Partnership To Advance The Future Of Surgery

Genesis MedTech Group and the National University Health System (NUHS) have formed a strategic partnership to advance artificial intelligence (AI...

November 19, 2025 | News

Debiopharm Transitions JCA Mauvernay Award Into New IDEAL Japan Programme To Drive Next Generation Oncology Research

After 20 years of the prestigious JCA (Japanese Cancer Association) Mauvernay Award in Japan, Debiopharm is now transitioning its longstanding support ...

November 19, 2025 | News

BostonGene and Kyoto University Launch AI Collaboration to Advance Precision Treatment for Esophageal Cancer

-BostonGene, developer of the leading AI foundation model for cancer and the immune system, and Kyoto University, a research institution known for its...

November 14, 2025 | News

Agilent and NHCS Forge Five Year Partnership To Advance Metabolic Heart Failure Research

Agilent Technologies Inc. (NYSE: A) announced the signing of a five-year Memorandum of Understanding (MOU) with National Heart Centre Singapore (...

November 14, 2025 | News

Genezen Partners with Humane Genomics to Manufacture Novel Oncolytic Therapy for Paediatric Liver Cancer

Genezen, a leading viral vector Contract Development and Manufacturing Organization (CDMO), and Humane Genomics, a biotechnology company developing oncolyt...

November 13, 2025 | News

Medit and OraQ Announce Strategic Partnership to Advance AI-Driven Intelligence in Digital Dentistry

The partnership brings together Medit's open, global digital platform and OraQ's advanced AI technologies to create new pathways for innovation and connect...

November 13, 2025 | News

Thermo Fisher Wins 510(k) Nod for EXENT System to Advance Myeloma Diagnosis

First-of-its-kind, automated system delivers increased sensitivity, specific identification of disease markers and improved laboratory workflow to support ...

November 13, 2025 | News

MGI Tech, SAMRC and DSTI Launch Africa’s First DNBSEQ-T7 Sequencer and 110K Human Genome Program in South Africa

MGI Tech Co., Ltd., a company dedicated to developing core tools and technologies that drive innovation in life sciences, announced two historic milestones...

November 12, 2025 | News

Stay Connected